The search terms are glucagon-like peptide-1 receptor agonist (including exenatide, liraglutide, albiglutide, lixisenatide, semaglutide, dulaglutide, taspoglutide), sodium glucose cotransporter 2 inhibitor (including canagliflozin, empagliflozin, dapagliflozin, ipragliflozin, luseogliflozin, tofogliflozin, remogliflozin, sergliflozin, sotagliflozin, ertugliflozin) and type 2 diabetes mellitus
Why Is Semaglutide Being Compounded
Instead, the FDA found different ingredients in the product, such as salt forms of GLP-1 agonists, which are different chemical entities
This could be considered in future therapies
Interact with neurotransmitter systems , possibly affecting serotonin, dopamine, and GABA signaling pathways
FDA hasnt approved it yet as we need more studies to explore its efficacy in humans